JP2006528233A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528233A5
JP2006528233A5 JP2006530503A JP2006530503A JP2006528233A5 JP 2006528233 A5 JP2006528233 A5 JP 2006528233A5 JP 2006530503 A JP2006530503 A JP 2006530503A JP 2006530503 A JP2006530503 A JP 2006530503A JP 2006528233 A5 JP2006528233 A5 JP 2006528233A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
linolenic acid
triglyceride
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006530503A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528233A (ja
Filing date
Publication date
Priority claimed from GBGB0311081.4A external-priority patent/GB0311081D0/en
Application filed filed Critical
Publication of JP2006528233A publication Critical patent/JP2006528233A/ja
Publication of JP2006528233A5 publication Critical patent/JP2006528233A5/ja
Pending legal-status Critical Current

Links

JP2006530503A 2003-05-14 2004-05-14 神経変性状態の治療 Pending JP2006528233A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0311081.4A GB0311081D0 (en) 2003-05-14 2003-05-14 Treatment of neurodegenerative conditions
US49733203P 2003-08-25 2003-08-25
PCT/GB2004/002089 WO2004100943A1 (en) 2003-05-14 2004-05-14 Use of triglyceride oils containing gamma-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011053394A Division JP2011144195A (ja) 2003-05-14 2011-03-10 神経変性状態の治療

Publications (2)

Publication Number Publication Date
JP2006528233A JP2006528233A (ja) 2006-12-14
JP2006528233A5 true JP2006528233A5 (enExample) 2007-06-28

Family

ID=9958058

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006530503A Pending JP2006528233A (ja) 2003-05-14 2004-05-14 神経変性状態の治療
JP2011053394A Pending JP2011144195A (ja) 2003-05-14 2011-03-10 神経変性状態の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011053394A Pending JP2011144195A (ja) 2003-05-14 2011-03-10 神経変性状態の治療

Country Status (15)

Country Link
US (2) US7935729B2 (enExample)
EP (2) EP2311450A1 (enExample)
JP (2) JP2006528233A (enExample)
CN (2) CN1901898A (enExample)
AU (1) AU2004237936B2 (enExample)
CA (1) CA2524036C (enExample)
CH (1) CH699430B1 (enExample)
DE (1) DE112004000762T5 (enExample)
ES (1) ES2294914B2 (enExample)
FI (1) FI122130B (enExample)
GB (2) GB0311081D0 (enExample)
IS (1) IS8083A (enExample)
NO (1) NO20055937L (enExample)
SE (1) SE531985C2 (enExample)
WO (1) WO2004100943A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
GB2442161B (en) * 2003-08-18 2008-05-21 Btg Int Ltd Triglycerides
GB2442164B (en) * 2003-08-18 2008-05-21 Btg Int Ltd Treatment of neurodegenerative conditions
ES2304094B2 (es) * 2003-08-18 2010-10-14 Btg International Limited Tratamiento de dolencias neurodegenerativas.
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
WO2008117062A1 (en) 2007-03-28 2008-10-02 Aker Biomarine Asa Bioeffective krill oil compositions
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US8372812B2 (en) 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
WO2011047091A1 (en) * 2009-10-13 2011-04-21 Martek Biosciences Corporation Methods for treating traumatic brain injury
US9500382B2 (en) 2010-04-21 2016-11-22 Honeywell International Inc. Automatic calibration of a demand control ventilation system
US9255720B2 (en) 2010-04-21 2016-02-09 Honeywell International Inc. Demand control ventilation system with commissioning and checkout sequence control
US8918218B2 (en) 2010-04-21 2014-12-23 Honeywell International Inc. Demand control ventilation system with remote monitoring
DK2409695T3 (en) 2010-07-05 2018-05-28 Beth Israel Deaconess Medical Ct Inc SN-2-MONOACYLGYLYCEROLS AND LIPID MALABSORPTION
US8719720B2 (en) 2010-09-24 2014-05-06 Honeywell International Inc. Economizer controller plug and play system recognition with automatic user interface population
US20140044827A1 (en) 2012-08-10 2014-02-13 Bodygenex LLC Dietary supplement containing lyophilized dairy and linolenic acid
CN105263321B (zh) 2013-03-28 2018-07-27 哥伦比亚大学纽约管理委员会 用omega-3甘油酯再灌注促进对用于移植的供体器官的保护
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
EP3027063B1 (en) 2013-08-01 2018-11-21 Bunge Loders Croklaan B.V. Opo glyceride composition
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
US10060642B2 (en) 2014-10-22 2018-08-28 Honeywell International Inc. Damper fault detection
US9845963B2 (en) 2014-10-31 2017-12-19 Honeywell International Inc. Economizer having damper modulation
KR20170118125A (ko) 2015-02-11 2017-10-24 에이커 바이오마린 앤탁틱 에이에스 지질 추출 공정
AU2016217566B2 (en) 2015-02-11 2019-02-14 Aker Biomarine Human Ingredients As Lipid compositions
RS63124B1 (sr) 2018-03-08 2022-05-31 Incyte Corp Aminopirazin diol jedinjenja kao pi3k-y inhibitori
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2077371A (en) 1937-04-13 Synthetic drx
US2077731A (en) * 1935-09-24 1937-04-20 Albert J Aaby Chimney scraper
US2617791A (en) * 1949-09-15 1952-11-11 Trojan Powder Co Recovery of valuable products from pentaerythritol mother liquor
US3158541A (en) * 1959-12-18 1964-11-24 Escambia Chem Corp Product for reduction of blood cholesterol concentration
US3082228A (en) * 1959-12-18 1963-03-19 Escambia Chem Corp Method for producing monoesters of polyunsaturated fatty acids
FR2003425A1 (fr) * 1968-03-07 1969-11-07 Unilever Nv Compositions grasses plastiques comestibles et procede pour les preparer
US3671563A (en) * 1968-04-19 1972-06-20 Smith Kline French Lab Glycerol 3-(2,2,2-trichloroethyl) carbonate
US3558656A (en) * 1968-04-19 1971-01-26 Smith Kline French Lab Glycerol trichloroethyl carbonate and derivatives
US3676472A (en) * 1969-07-28 1972-07-11 American Home Prod Certain linoleic and linolenic acid ester fractions of vegetable oils and derivatives thereof
US3748348A (en) * 1970-07-27 1973-07-24 Lever Brothers Ltd Directed-interesterified glyceridic oils having a high linoleic acid content and process for their production
US3671557A (en) * 1970-09-17 1972-06-20 Smith Kline French Lab 1,2-diacylglycerol 3-(2,2,2-trichloroethyl) carbonates
GB1370021A (en) * 1971-03-25 1974-10-09 Unilever Ltd Process for preparing usaturated carboxylic acids
US3855254A (en) 1972-03-31 1974-12-17 Lever Brothers Ltd Interesterification process
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents
US3988446A (en) 1974-11-07 1976-10-26 Abbott Laboratories Glycerides with anti-inflammatory properties
US3972907A (en) * 1975-03-24 1976-08-03 G. D. Searle & Co. Anti-hyperlipidemic fatty acids and esters
US4048202A (en) * 1975-04-11 1977-09-13 G. D. Searle & Co. 3-O-Alkanoylglyceric acids
US4181670A (en) * 1978-12-11 1980-01-01 G. D. Searle & Co. Phenyl 5Z,8Z,11Z,14Z-eicosatetraenoate and congeners
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
US4701468A (en) * 1983-04-15 1987-10-20 Roussel-Uclaf Oxidized triglycerides having therapeutic utility
US4607052A (en) * 1983-04-15 1986-08-19 Roussel-Uclaf Triglycerides, dietetic and therapeutical applications and compositions containing them
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
GB8404463D0 (en) * 1984-02-21 1984-03-28 Efamol Ltd Microbiological production of essential fatty acids
US5077312A (en) 1984-07-08 1991-12-31 Oncogen Biologically active lipids binding membrane receptors
GB2178752B (en) * 1985-07-12 1989-10-11 Unilever Plc Substitute milk fat
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
US5151291A (en) * 1985-12-27 1992-09-29 Nisshin Flour Milling Co., Ltd. Glycerides of eicosapentaenoic acid, processes for preparing the same and oil and fat products containing the same
US5306730A (en) * 1986-02-03 1994-04-26 Kabushiki Kaisha Yakult Honsha Botulinum toxin neutralizer
US5227403A (en) * 1986-10-01 1993-07-13 The Nisshin Oil Mills, Ltd. Fats and oils having superior digestibility and absorptivity
US4867965A (en) * 1986-10-02 1989-09-19 Revlon, Inc. Fatty acid diesters
FR2617161B1 (fr) 1987-06-29 1989-10-27 Azar Robert Nouveaux glycerides d'acide gras insature et leur procede d'obtention
US4832975A (en) * 1987-09-29 1989-05-23 The Procter & Gamble Company Tailored triglycerides having improved autoignition characteristics
US5008126A (en) * 1989-06-27 1991-04-16 Nabisco Brands, Inc. Long chain diol diesters as low calorie fat mimetics
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
GB9026648D0 (en) 1990-12-07 1991-01-23 Efamol Holdings Nutrition
PH11992043811B1 (en) 1991-01-24 2002-08-22 Martek Corp Arachidonic acid and methods for the production and use thereof
US5658767A (en) 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
GB9111900D0 (en) 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
US5618955A (en) * 1992-11-30 1997-04-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Fatty acid derivatives and pharmaceutical compositions containing same
EP0679057B1 (en) 1993-01-15 1999-08-18 Abbott Laboratories Structured lipids
GB9301446D0 (en) 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage
JPH06279311A (ja) 1993-03-26 1994-10-04 Sagami Chem Res Center プロテインキナーゼcアイソザイムの活性化剤
JPH0741421A (ja) 1993-05-28 1995-02-10 Suntory Ltd ロイコトリエンb4 (ltb4 )による医学的症状の予防及び改善剤
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5663450A (en) * 1993-08-17 1997-09-02 Cv Therapeutics Macrophage lipid chemoattractant
WO1995017889A1 (en) * 1993-12-29 1995-07-06 Kowa Tekuno Sachi Co., Ltd. Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
JPH07309773A (ja) 1994-05-16 1995-11-28 Sagami Chem Res Center アセチルコリン放出促進剤
FR2722410B1 (fr) 1994-07-15 1996-10-04 Grinda Jean Robert Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique
JP3770628B2 (ja) 1994-08-09 2006-04-26 サントリー株式会社 遅延型アレルギー反応を介する医学的症状の予防及び改善剤
NZ280017A (en) 1994-09-21 1997-06-24 Scotia Holdings Plc Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
EP0711503A3 (en) 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5990163A (en) 1995-01-13 1999-11-23 The Salk Institute For Biological Studies Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor
DE19503993A1 (de) 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US6410078B1 (en) * 1995-04-28 2002-06-25 Loders-Croklaan B.V. Triglycerides, rich in polyunsaturated fatty acids
KR100490189B1 (ko) 1995-08-07 2005-05-17 산토리 가부시키가이샤 오메가 9계 불포화 지방산을 포함하는, 연골 조직의 이상에 기인하는 의학적 증상의 예방 또는 치료제
GB9519661D0 (en) 1995-09-27 1995-11-29 Scotia Holdings Plc Fatty acid treatment
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6262119B1 (en) * 1996-04-12 2001-07-17 Peptide Technology Limited Methods of treating immunopathologies using polyunsaturated fatty acids
US5753702A (en) * 1996-05-22 1998-05-19 University Of Vermont Arachidonic acid metabolite, 16-hete
US6340485B1 (en) * 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
ES2196333T5 (es) 1996-06-03 2007-09-01 Croda International Plc Composiciones de aceites vegetales.
AU3349697A (en) * 1996-06-29 1998-01-21 Scottish Agricultural College Improvement of male fertility with antioxidants and/or polyunsaturated fatty acids
GB9617847D0 (en) * 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
WO1998016216A1 (en) * 1996-10-11 1998-04-23 Scotia Holdings Plc Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
NZ337039A (en) * 1997-02-21 2001-06-29 Univ Tennessee Res Corp Use of polyunsaturated fatty acids for reducing the incidence of necrotizing entercolitis
US6201022B1 (en) * 1997-03-27 2001-03-13 Myorx, Inc. Methods for treating neurotransmitter-mediated pain syndromes by topically administering an omega fatty acid
US6051754A (en) * 1997-04-11 2000-04-18 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US6432684B1 (en) * 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
US20020037876A1 (en) * 1998-06-25 2002-03-28 Yissum Research Development Company Of Hebrew University Of Jerusalem Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
FR2765482B1 (fr) 1997-07-07 2000-12-08 Oreal Utilisation de l'acide y-linolenique pour prevenir le stress oxydatif
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
EP0919230A1 (en) 1997-12-01 1999-06-02 Societe Des Produits Nestle S.A. NMIFA's as anti-inflammatory agents in superficial mammal tissues
EP1066235B1 (en) 1998-04-03 2003-10-01 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Synthetic endogenous cannabinoid analogues and uses thereof
US7101914B2 (en) * 1998-05-04 2006-09-05 Natural Asa Isomer enriched conjugated linoleic acid compositions
US6214372B1 (en) * 1998-05-04 2001-04-10 Con Lin Co., Inc. Method of using isomer enriched conjugated linoleic acid compositions
US6696584B2 (en) * 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
CN1219064C (zh) * 1998-08-04 2005-09-14 嘉吉有限公司 植物脂肪酸去饱和酶启动子
KR100325581B1 (ko) * 1998-08-07 2002-08-24 오우택 아라키토닉산의리폭시게네이즈대사결과물질을함유하는진통제용조성물
WO2000009118A1 (en) * 1998-08-13 2000-02-24 The Wistar Institute Methods for reducing atherosclerotic plaques
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
DE10029562A1 (de) 1999-06-24 2001-03-01 Strathmann Ag & Co Lipophile Brennesselextrakte, Verfahren zu deren Herstellung und ihre Verwendung
DE19930030B4 (de) 1999-06-30 2004-02-19 Meduna Arzneimittel Gmbh CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform
FR2797584B1 (fr) 1999-08-16 2008-07-25 Stephane Desjonqueres Utilisation de lipides peroxydes dans le traitement ou la prevention des plaies et inflammations des muqueuses de la cavite buccale
JP3779505B2 (ja) 1999-08-24 2006-05-31 花王株式会社 油脂組成物
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
PT1088552E (pt) 1999-09-30 2006-06-30 Loders Croklaan Bv Composicoes contendo acido pinolenico e sua utilizacao como componente na saude
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US20010047036A1 (en) 1999-12-17 2001-11-29 Vanderhoof Jon A. Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome
EG22407A (en) * 2000-02-17 2003-01-29 Iams Company Method for improving bone modeling and chondrocyte functioning in growing canines
US6361806B1 (en) * 2000-02-23 2002-03-26 Michael P. Allen Composition for and method of topical administration to effect changes in subcutaneous adipose tissue
DE60101859T2 (de) 2000-02-24 2004-12-30 Unilever N.V. Pinolensäure gegen Diabetes
JP2003535892A (ja) 2000-06-23 2003-12-02 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 2−アラキドニルグリセロール(2−AG)−腫瘍壊死因子−αの阻害剤および閉鎖性頭部損傷における脳の神経保護因子
GB0016045D0 (en) 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd IgE産生抑制剤
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
FR2815227B1 (fr) * 2000-10-17 2003-04-11 Schwartz Laboratoires Robert Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
NO20005718A (no) * 2000-11-13 2001-06-05 Ethics Cosmeceuticals Ab Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugert vitamin A samt fremgangsmåte for fremstilling og anvendelse av denne
US6528040B1 (en) * 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
EP1372641A4 (en) * 2001-03-05 2004-08-25 Stephen P Ernest ENTERAL FORMULATION
MXPA03010888A (es) 2001-05-30 2004-02-27 Laxdale Ltd Coenzimas q y acido eicosapentaenoico (epa).
JPWO2003004667A1 (ja) * 2001-07-02 2004-10-28 サントリー株式会社 高度不飽和脂肪酸含有トリグリセリドを含む油脂の製造方法
JP2003048831A (ja) 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
EP1285590A1 (en) * 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
AU784852B2 (en) 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US6677470B2 (en) * 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
ITMI20012732A1 (it) 2001-12-20 2003-06-20 Health Pharma S R L Integratore alimentare per neuropatici
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils
US7163960B2 (en) * 2002-03-08 2007-01-16 Monsanto Technology L.L.C. Treatment and prevention of inflammatory disorders
US20040048926A1 (en) * 2002-03-15 2004-03-11 Hoffman Dennis Robert Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months
KR20050024274A (ko) 2002-05-17 2005-03-10 니켄 가가쿠 가부시키가이샤 TGF-α 발현 억제제
US7335481B2 (en) * 2002-07-24 2008-02-26 Christer Owman Methods of identifying compounds that affect a fatty acid cell-surface receptor
EP1569620A4 (en) 2002-10-30 2006-03-22 Spherics Inc NANOPARTICULAR BIOACTIVE AGENTS
US7074418B2 (en) * 2002-11-18 2006-07-11 Changaris David G Conjugated fatty acid based emulsion and methods for preparing and using same
US20040229950A1 (en) 2002-11-26 2004-11-18 Vanderhoek Jack Y. Method and composition with conjugated linoleic acid esters
US6841573B2 (en) * 2002-11-27 2005-01-11 Molecular Nutrition Use of arachidonic acid as a method of increasing skeletal muscle mass
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
US20040208939A1 (en) * 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
ES2304094B2 (es) 2003-08-18 2010-10-14 Btg International Limited Tratamiento de dolencias neurodegenerativas.
WO2005063231A2 (en) 2003-12-31 2005-07-14 Igennus Limited Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or esther thereof

Similar Documents

Publication Publication Date Title
JP2006528233A5 (enExample)
NZ627238A (en) Stable pharmaceutical composition comprising ethyl eicosapentaenoate
CN100423718C (zh) 治疗精神性和神经性疾病的高纯乙基epa及其他epa衍生物
EP0347056B1 (en) Essential fatty acid compositions
EP1982710B1 (en) Composition for prevention of recurrence of stroke
SI2443246T1 (en) Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
WO2009091538A3 (en) Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia
JP5087280B2 (ja) 中枢神経系障害の治療のための、選択されたn−3系脂肪酸の高度濃縮組成物の使用
JPS60115522A (ja) 血中のコレステロ−ル及びトリグリセリドのレベルを低下させるための複合脂肪酸組成物
IL158678A (en) Use of fatty acids in combination with an enzyme inhibitor in drug beating
JP2013521310A5 (enExample)
CN102481324A (zh) 调节脂质成分的组合物和方法
CN103458893A (zh) Sn-1(3)单酰基甘油酯和脂质吸收
JP2016053065A5 (enExample)
Yoon et al. Polyunsaturated fatty acid-enriched diet therapy for a child with epilepsy
JP2006219454A5 (enExample)
JP2014515928A (ja) 認知機能減退に対する医療食品
EP0087865A2 (en) Pharmaceutical composition
SG184765A1 (en) Compositions containing sesamin-class compound(s) and arachidonic acid class compound(s)
CA2631343C (en) The combination of omega-3 fatty acids and thyroid hormone for treating alzheimer&#39;s dementia
CN106031722A (zh) 治疗身体和神经系统失调或炎症引起的疾病的组合物及应用
WO2008072385A1 (ja) 体脂肪の蓄積に起因する疾患の治療剤
JP5702292B2 (ja) パーキンソン病患者の内臓脂肪減少抑制剤
WO2021182403A1 (ja) 認知機能の低下抑制および/または改善用組成物
JP5860803B2 (ja) 生体内の蛋白質の分解抑制剤